Osteoarthritis Implementing NICE guidance 2008 NICE clinical guideline














- Slides: 14
Osteoarthritis Implementing NICE guidance 2008 NICE clinical guideline 59
What this presentation covers Background Holistic assessment and targeting treatment Key priorities for implementation - Core treatment Adjuncts to core therapy Costs and savings Discussion Find out more
Background • Osteoarthritis refers to a clinical syndrome of joint pain accompanied by varying degrees of functional limitation and reduced quality of life. • It is the most common form of arthritis and one of the leading causes of pain and disability worldwide. • It is not caused by ageing and does not necessarily deteriorate. • It is a metabolically active repair process which is slow and can result in a structurally altered but symptom-free joint.
Holistic assessment A holistic approach to osteoarthritis assessment and management is needed. Healthcare professionals should assess the effect of osteoarthritis on the individual’s function, quality of life, occupation, mood, relationships, and leisure activities.
Targeting treatment oral NSAIDs including COX-2 inhibitors opioids capsaicin intra-articular corticosteroid injections paracetamol supports and braces topical NSAIDs education, advice, information access shock-absorbing shoes or insoles strengthening exercise aerobic fitness training assistive devices weight loss if overweight/obese TENS manual therapy (manipulation and stretching) local heat and cold joint arthroplasty
Core treatment Exercise should be a core treatment for people with osteoarthritis, irrespective of age, comorbidity, pain severity or disability. Exercise should include: • local muscle strengthening, and • general aerobic fitness.
Adjunct to core therapy: paracetamol Healthcare professionals should consider offering paracetamol for pain relief in addition to core treatment; regular dosing may be required. Paracetamol and/or topical non-steroidal antiinflammatory drugs (NSAIDs) should be considered ahead of oral NSAIDs, cyclo-oxygenase 2 (COX-2) inhibitors or opioids.
Adjunct to core therapy: topical treatments Healthcare professionals should consider offering topical NSAIDs for pain relief in addition to core treatment for people with knee or hand osteoarthritis. Topical NSAIDs and/or paracetamol should be considered ahead of oral NSAIDs, COX-2 inhibitors or opioids.
Adjunct to core therapy: Oral NSAID/Cox-2 inhibitors When offering treatment with an oral NSAID/COX-2 inhibitor, the first choice should be either a standard NSAID or a COX-2 inhibitor (other than etoricoxib 60 mg). In either case, these should be co-prescribed with a proton pump inhibitor (PPI), choosing the one with the lowest acquisition cost.
Adjunct to core therapy: referral criteria for surgery Referral for joint replacement surgery should be considered for people with osteoarthritis who experience joint symptoms that have a substantial impact on their quality of life and are refractory to non-surgical treatment. Referral should be made before there is prolonged and established functional limitation and severe pain.
Adjunct to core therapy: invasive treatments for knee osteoarthritis Referral for arthroscopic lavage and debridement should not be offered as part of treatment for osteoarthritis, unless the person has knee osteoarthritis with a clear history of mechanical locking (not gelling, ‘giving way’ or X-ray evidence of loose bodies).
Costs and savings per 100, 000 population Recommendations with significant costs Costs (£ per year) Topical NSAIDs 18, 000 Proton pump inhibitors 23, 000 Estimated cost of implementation 41, 000 Recommendations with significant savings Invasive treatments Oral NSAIDS Savings (£ per year) – 52, 000 -5, 000 Estimated saving of implementation – 57, 000 Total net saving of implementing the guideline -16, 000
Discussion • Which core recommendations present the most challenges for local practice? • Offering topical NSAIDs before oral dosage forms is likely to be a change to established clinical patterns. What needs to happen and by when? • What changes do we need to make in relation to surgical services and the way we commission them? • What are the next steps to be considered in implementing the core treatments locally?
Find out more Visit www. nice. org. uk/CG 059 for: • Other guideline formats • Costing report and template • Audit support